Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.34
STJ's Cash to Debt is ranked higher than
54% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. STJ: 0.34 )
STJ' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.34

Equity to Asset 0.40
STJ's Equity to Asset is ranked higher than
53% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. STJ: 0.40 )
STJ' s 10-Year Equity to Asset Range
Min: 0.38   Max: 0.83
Current: 0.4

0.38
0.83
Interest Coverage 12.98
STJ's Interest Coverage is ranked higher than
55% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 235.10 vs. STJ: 12.98 )
STJ' s 10-Year Interest Coverage Range
Min: 7.08   Max: 9999.99
Current: 12.98

7.08
9999.99
F-Score: 6
Z-Score: 3.53
M-Score: -2.69
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 18.18
STJ's Operating margin (%) is ranked higher than
93% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. STJ: 18.18 )
STJ' s 10-Year Operating margin (%) Range
Min: 13.95   Max: 38.93
Current: 18.18

13.95
38.93
Net-margin (%) 15.70
STJ's Net-margin (%) is ranked higher than
92% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. STJ: 15.70 )
STJ' s 10-Year Net-margin (%) Range
Min: 2.17   Max: 22.02
Current: 15.7

2.17
22.02
ROE (%) 21.33
STJ's ROE (%) is ranked higher than
95% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. STJ: 21.33 )
STJ' s 10-Year ROE (%) Range
Min: 3.02   Max: 23.7
Current: 21.33

3.02
23.7
ROA (%) 8.60
STJ's ROA (%) is ranked higher than
89% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. STJ: 8.60 )
STJ' s 10-Year ROA (%) Range
Min: 1.65   Max: 15.43
Current: 8.6

1.65
15.43
ROC (Joel Greenblatt) (%) 36.92
STJ's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. STJ: 36.92 )
STJ' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 20.24   Max: 71.9
Current: 36.92

20.24
71.9
Revenue Growth (3Y)(%) 6.60
STJ's Revenue Growth (3Y)(%) is ranked higher than
79% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. STJ: 6.60 )
STJ' s 10-Year Revenue Growth (3Y)(%) Range
Min: -6.7   Max: 28.9
Current: 6.6

-6.7
28.9
EBITDA Growth (3Y)(%) -4.60
STJ's EBITDA Growth (3Y)(%) is ranked higher than
70% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. STJ: -4.60 )
STJ' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -4.6   Max: 22.2
Current: -4.6

-4.6
22.2
EPS Growth (3Y)(%) -3.30
STJ's EPS Growth (3Y)(%) is ranked higher than
73% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. STJ: -3.30 )
STJ' s 10-Year EPS Growth (3Y)(%) Range
Min: -37   Max: 120.5
Current: -3.3

-37
120.5
» STJ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

STJ Guru Trades in Q4 2013

Andreas Halvorsen 1,486,735 sh (New)
John Hussman 350,000 sh (New)
Paul Tudor Jones 11,101 sh (+164.31%)
Jeremy Grantham 224,404 sh (+8.18%)
John Buckingham 110,152 sh (+3.25%)
James Barrow 3,151,847 sh (+2.91%)
John Rogers 1,604,471 sh (+1.99%)
Vanguard Health Care Fund 6,297,900 sh (unchged)
Bill Frels 2,110,787 sh (-0.39%)
Mario Gabelli 73,189 sh (-1.92%)
Ken Fisher 267,380 sh (-13.63%)
Joel Greenblatt 17,326 sh (-36.01%)
David Dreman 27,489 sh (-44.61%)
Steven Cohen 19,952 sh (-92.71%)
» More
Q1 2014

STJ Guru Trades in Q1 2014

Louis Moore Bacon 6,670 sh (New)
Pioneer Investments 79,135 sh (New)
Steven Cohen 369,148 sh (+1750.18%)
Jeremy Grantham 804,577 sh (+258.54%)
David Dreman 47,202 sh (+71.71%)
Paul Tudor Jones 15,868 sh (+42.94%)
Andreas Halvorsen 1,901,750 sh (+27.91%)
Joel Greenblatt Sold Out
John Buckingham 109,649 sh (-0.46%)
Bill Frels 2,098,745 sh (-0.57%)
Ken Fisher 257,270 sh (-3.78%)
Vanguard Health Care Fund 5,844,300 sh (-7.2%)
James Barrow 2,917,285 sh (-7.44%)
John Rogers 1,404,552 sh (-12.46%)
John Hussman 300,000 sh (-14.29%)
Mario Gabelli 12,400 sh (-83.06%)
» More
Q2 2014

STJ Guru Trades in Q2 2014

Jim Simons 516,013 sh (New)
Joel Greenblatt 4,264 sh (New)
Mario Gabelli 37,400 sh (+201.61%)
Jeremy Grantham 1,736,038 sh (+115.77%)
Pioneer Investments 80,823 sh (+2.13%)
Ken Fisher 260,414 sh (+1.22%)
John Buckingham 110,899 sh (+1.14%)
James Barrow 2,940,885 sh (+0.81%)
Steven Cohen 186,200 sh (unchged)
Andreas Halvorsen Sold Out
Louis Moore Bacon Sold Out
Bill Frels 2,097,512 sh (-0.06%)
John Rogers 1,220,316 sh (-13.12%)
John Hussman 250,000 sh (-16.67%)
Vanguard Health Care Fund 4,301,100 sh (-26.41%)
David Dreman 31,736 sh (-32.77%)
Paul Tudor Jones 7,593 sh (-52.15%)
» More
Q3 2014

STJ Guru Trades in Q3 2014

Ray Dalio 70,236 sh (New)
Joel Greenblatt 40,718 sh (+854.92%)
Paul Tudor Jones 24,056 sh (+216.82%)
Jim Simons 615,713 sh (+19.32%)
Jeremy Grantham 1,802,341 sh (+3.82%)
James Barrow 2,982,885 sh (+1.43%)
John Buckingham 111,888 sh (+0.89%)
John Rogers 1,227,309 sh (+0.57%)
Mario Gabelli 37,400 sh (unchged)
John Hussman 250,000 sh (unchged)
Pioneer Investments Sold Out
Bill Frels 2,090,259 sh (-0.35%)
David Dreman 31,333 sh (-1.27%)
Ken Fisher 255,663 sh (-1.82%)
Vanguard Health Care Fund 3,932,200 sh (-8.58%)
Steven Cohen 29,300 sh (-84.26%)
» More
» Details

Insider Trades

Latest Guru Trades with STJ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ray Dalio 2014-09-30 New Buy0.03%$61.14 - $70.32 $ 67.173%70236
Joel Greenblatt 2014-09-30 Add 854.92%0.02%$61.14 - $70.32 $ 67.173%40718
Andreas Halvorsen 2014-06-30 Sold Out 0.52%$61.64 - $70.46 $ 67.174%0
Vanguard Health Care Fund 2014-06-30 Reduce -26.41%0.29%$61.64 - $70.46 $ 67.174%4301100
John Hussman 2014-06-30 Reduce -16.67%0.25%$61.64 - $70.46 $ 67.174%250000
John Rogers 2014-06-30 Reduce -13.12%0.14%$61.64 - $70.46 $ 67.174%1220316
David Dreman 2014-06-30 Reduce -32.77%0.08%$61.64 - $70.46 $ 67.174%31736
Mario Gabelli 2014-06-30 Add 201.61%0.01%$61.64 - $70.46 $ 67.174%37400
Joel Greenblatt 2014-06-30 New Buy$61.64 - $70.46 $ 67.174%4264
John Hussman 2014-03-31 Reduce -14.29%0.21%$59.4 - $68.48 $ 67.174%300000
John Rogers 2014-03-31 Reduce -12.46%0.15%$59.4 - $68.48 $ 67.173%1404552
Andreas Halvorsen 2014-03-31 Add 27.91%0.11%$59.4 - $68.48 $ 67.173%1901750
David Dreman 2014-03-31 Add 71.71%0.1%$59.4 - $68.48 $ 67.173%47202
Joel Greenblatt 2014-03-31 Sold Out 0.03%$59.4 - $68.48 $ 67.173%0
Mario Gabelli 2014-03-31 Reduce -83.06%0.02%$59.4 - $68.48 $ 67.173%12400
John Hussman 2013-12-31 New Buy1.5%$54.58 - $62.74 $ 67.1716%350000
Andreas Halvorsen 2013-12-31 New Buy0.43%$54.58 - $62.74 $ 67.1716%1486735
David Dreman 2013-12-31 Reduce -44.61%0.11%$54.58 - $62.74 $ 67.1716%27489
Joel Greenblatt 2013-12-31 Reduce -36.01%0.02%$54.58 - $62.74 $ 67.1716%17326
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about St Jude Medical Inc

Weekly 52-Week Highs Highlight: PPG, STJ, V, LLTC, LUV
According to GuruFocus list of 52-week highs, PPG Industries Inc., St Jude Medical Inc., Visa Inc., Linear Technology and Southwest Airlines Co. have all recently reached their 52-week highs. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 22.20
STJ's P/E(ttm) is ranked higher than
89% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 84.60 vs. STJ: 22.20 )
STJ' s 10-Year P/E(ttm) Range
Min: 12.71   Max: 51.32
Current: 22.2

12.71
51.32
P/B 4.68
STJ's P/B is ranked higher than
67% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. STJ: 4.68 )
STJ' s 10-Year P/B Range
Min: 2.13   Max: 8.2
Current: 4.68

2.13
8.2
P/S 3.49
STJ's P/S is ranked higher than
70% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. STJ: 3.49 )
STJ' s 10-Year P/S Range
Min: 1.84   Max: 7.3
Current: 3.49

1.84
7.3
PFCF 19.47
STJ's PFCF is ranked higher than
93% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. STJ: 19.47 )
STJ' s 10-Year PFCF Range
Min: 9.89   Max: 41.61
Current: 19.47

9.89
41.61
EV-to-EBIT 21.42
STJ's EV-to-EBIT is ranked higher than
84% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 61.55 vs. STJ: 21.42 )
STJ' s 10-Year EV-to-EBIT Range
Min: 10   Max: 34.3
Current: 21.42

10
34.3
PEG 74.00
STJ's PEG is ranked higher than
87% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. STJ: 74.00 )
STJ' s 10-Year PEG Range
Min: 0.72   Max: 1154.5
Current: 74

0.72
1154.5
Shiller P/E 27.04
STJ's Shiller P/E is ranked higher than
92% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. STJ: 27.04 )
STJ' s 10-Year Shiller P/E Range
Min: 14.56   Max: 74.61
Current: 27.04

14.56
74.61
Current Ratio 1.93
STJ's Current Ratio is ranked higher than
61% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. STJ: 1.93 )
STJ' s 10-Year Current Ratio Range
Min: 1.15   Max: 4.53
Current: 1.93

1.15
4.53
Quick Ratio 1.52
STJ's Quick Ratio is ranked higher than
64% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. STJ: 1.52 )
STJ' s 10-Year Quick Ratio Range
Min: 0.9   Max: 3.54
Current: 1.52

0.9
3.54

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.58
STJ's Dividend Yield is ranked higher than
61% of the 185 Companies
in the Global Medical Devices industry.

( Industry Median: 1.35 vs. STJ: 1.58 )
STJ' s 10-Year Dividend Yield Range
Min: 0.39   Max: 2.81
Current: 1.58

0.39
2.81
Dividend Payout 0.35
STJ's Dividend Payout is ranked higher than
88% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. STJ: 0.35 )
STJ' s 10-Year Dividend Payout Range
Min: 0.28   Max: 0.63
Current: 0.35

0.28
0.63
Yield on cost (5-Year) 1.60
STJ's Yield on cost (5-Year) is ranked higher than
52% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. STJ: 1.60 )
STJ' s 10-Year Yield on cost (5-Year) Range
Min: 0.39   Max: 2.81
Current: 1.6

0.39
2.81
Share Buyback Rate 4.20
STJ's Share Buyback Rate is ranked higher than
97% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -1.10 vs. STJ: 4.20 )
STJ' s 10-Year Share Buyback Rate Range
Min: 4.2   Max: -16.1
Current: 4.2

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.58
STJ's Price/DCF (Projected) is ranked higher than
92% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. STJ: 1.58 )
STJ' s 10-Year Price/DCF (Projected) Range
Min: 0.89   Max: 5.41
Current: 1.58

0.89
5.41
Price/Median PS Value 1.05
STJ's Price/Median PS Value is ranked higher than
76% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. STJ: 1.05 )
STJ' s 10-Year Price/Median PS Value Range
Min: 0.57   Max: 2.04
Current: 1.05

0.57
2.04
Earnings Yield (Greenblatt) 4.70
STJ's Earnings Yield (Greenblatt) is ranked higher than
85% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. STJ: 4.70 )
STJ' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.9   Max: 10
Current: 4.7

2.9
10
Forward Rate of Return (Yacktman) 4.53
STJ's Forward Rate of Return (Yacktman) is ranked higher than
78% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.52 vs. STJ: 4.53 )
STJ' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 4.4   Max: 24.6
Current: 4.53

4.4
24.6

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, EW » details
Traded in other countries:JUD.Germany,
St Jude Medical, Inc., was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company's principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) - tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) - vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company's commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an ext
» More Articles for STJ

Headlines

Articles On GuruFocus.com
Boston Scientific Lost the First Place in Innovation Dec 11 2014 
John Rogers Ariel Appreciation Fund Q3 Commentary Oct 25 2014 
EW: Potential for Capital Appreciation Oct 03 2014 
No More a Simple Distributor Sep 07 2014 
What Drives St. Jude Medical to Be More Diversified? Apr 30 2014 
Weekly 52-Week Highs Highlight: PPG, STJ, V, LLTC, LUV Dec 23 2013 
Renaissance Technologies - Heavy Selling in Third Quarter, AAPL, MST, STJ, Others Nov 14 2013 
Weekly CFO Sells Highlight: TXN, AAPL, MAN, DHR, STJ, BAX Jul 29 2013 
comment on STJ Apr 21 2013 
Sarah Ketterer Returns 24 Pct in 2012, Her Top Q4 Buys Feb 25 2013 

More From Other Websites
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014
St. Jude Medical's Quadra Allure Pacemaker Gets CE Mark Dec 12 2014
St. Jude Medical Announces CE Mark Approval of the World’s Only MultiPoint Pacing Pacemaker Dec 11 2014
St. Jude Medical Announces CE Mark Approval of the World’s Only MultiPoint Pacing Pacemaker Dec 11 2014
St. Jude Medical to Present Data from 16 Research Abstracts and Highlight Its Product Portfolio at... Dec 08 2014
St. Jude Medical to Present Data from 16 Research Abstracts and Highlight Its Product Portfolio at... Dec 08 2014
Holding(s) in Company Dec 05 2014
St. Jude Medical's CardioMEMS HF System Tests Positive Nov 19 2014
Data Shows the CardioMEMS HF System Significantly Reduced 30-Day Hospital Readmission Rates Nov 18 2014
Medtronic Earnings In Line; Sales Guidance Up Nov 18 2014
ST JUDE MEDICAL INC Financials Nov 11 2014
10-Q for St. Jude Medical, Inc. Nov 06 2014
Seven Obamacare Bills That The New GOP Senate Majority Should Pass In 2015 Nov 05 2014
ST JUDE MEDICAL INC Files SEC form 10-Q, Quarterly Report Nov 04 2014
Health care stocks hitting new highs Oct 27 2014
St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for... Oct 27 2014
St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for... Oct 27 2014
Post-Earnings Analyst Review - St. Jude Medical Oct 22 2014
Insight - U.S. government probes medical devices for possible cyber flaws Oct 22 2014
St. Jude Medical Announces Fourth Quarter Dividend Oct 21 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK